Provide strategic counsel and advocate on issues related to FDA policy and treatment of Non-Small Cell Lung Cancer
2026 · 1st Quarter (Jan 1 - Mar 31)
NUVATION BIO INC.
Filed by BGR GOVERNMENT AFFAIRS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- BGR GOVERNMENT AFFAIRS
- Client
- NUVATION BIO INC.
- Filing UUID
- 59411649-eb1f-4dfe-9ffe-51802634de2b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.